文献速递预防保健、筛查与疫苗慢病管理

结直肠癌筛查与预防

Colorectal Cancer Screening and Prevention.
PubMed 文献 · Am Fam Physician · 2018-01-01

结直肠癌是美国常见致病和致死原因,多起源于腺瘤性息肉或锯齿状息肉。对50至75岁平均风险成人筛查可降低发病率和死亡率。随机对照试验显示愈创木脂粪隐血试验和软式乙状结肠镜可降低结直肠癌特异性死亡率;结肠镜证据来自前瞻性队列研究。阿司匹林等药物及钙、奶制品、运动等生活方式因素可降低风险,但存在局限。

要点

  • 50至75岁平均风险成人应接受筛查以降低结直肠癌发病和死亡。
  • 愈创木脂粪隐血试验和软式乙状结肠镜有随机对照试验证据降低特异性死亡率。
  • 结肠镜有前瞻性队列证据降低发病和死亡,随机对照试验仍在进行。

核心结论

  • 对50至75岁平均风险成人进行筛查可降低结直肠癌发病率和死亡率。
  • 结肠镜降低结直肠癌发病和死亡的最佳证据来自前瞻性队列研究。

研究设计与样本

  • 本文为综述,汇总随机对照试验和前瞻性队列研究等证据。
  • 随机对照试验显示愈创木脂粪隐血试验和软式乙状结肠镜降低结直肠癌特异性死亡率。
  • 比较结肠镜与其他策略的随机对照试验仍在进行中。

主要发现

  • 愈创木脂粪隐血试验和软式乙状结肠镜有随机对照试验证据降低结直肠癌特异性死亡率。
  • 结肠镜有前瞻性队列证据显示降低结直肠癌发病率和相关死亡率。
  • 其他筛查选项包括粪便免疫化学检测、计算机断层结肠成像和多靶点粪便DNA检测联合粪便免疫化学检测。

关键数值与推荐

  • 对50至75岁平均风险成人进行筛查可降低结直肠癌发病率和死亡率。
  • 阿司匹林、非甾体抗炎药、环氧合酶-2抑制剂和激素治疗有良好证据降低结直肠癌和腺瘤性息肉风险,但潜在危害限制其应用。
  • 钙补充、适量奶制品摄入、减少红肉摄入、增加体力活动、降低体重指数和他汀使用有良好证据降低结直肠癌和腺瘤性息肉风险。
  • 增加酒精摄入和烟草使用与结直肠癌风险增加相关,但无直接证据表明减少饮酒或戒烟降低风险。

临床怎么用

  • 对50至75岁平均风险成人应提供结直肠癌筛查。
  • 筛查选项包括愈创木脂粪隐血试验、软式乙状结肠镜、粪便免疫化学检测、计算机断层结肠成像和多靶点粪便DNA检测联合粪便免疫化学检测。
  • 结肠镜可用于筛查,但其降低特异性死亡率的随机对照试验证据尚不充分。
  • 预防措施可考虑钙补充、适量奶制品、减少红肉、增加体力活动、降低体重指数和他汀使用,但需权衡证据局限性。

局限性

  • 结肠镜降低结直肠癌特异性死亡率缺乏随机对照试验证据,相关试验仍在进行。
  • 阿司匹林等药物预防的潜在危害限制其 usefulness。
  • 减少饮酒或戒烟降低结直肠癌风险缺乏直接证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Colorectal cancer is a common cause of morbidity and mortality in the United States. Most colorectal cancers arise from preexisting adenomatous or serrated polyps. The incidence and mortality of colorectal cancer can be reduced with screening of average-risk adults 50 to 75 years of age. Randomized controlled trials show evidence of reduced colorectal cancer-specific mortality with guaiac-based fecal occult blood tests and flexible sigmoidoscopy. There are no randomized controlled trials on the effectiveness of colonoscopy to reduce colorectal cancer-specific mortality; however, several randomized controlled trials comparing colonoscopy with other strategies are in progress. The best available evidence supporting colonoscopy is from prospective cohort studies that demonstrate decreased incidence of colorectal cancer and colorectal cancer-related mortality in individuals undergoing colonoscopy. Other screening options include fecal immunochemical testing, computed tomographic colonography, and multitargeted stool DNA testing combined with fecal immunochemical testing. There is good evidence that aspirin, nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 inhibitors, and hormone therapy decrease the risk of colorectal cancer and adenomatous polyps, but potential harms limit their usefulness. There is good evidence that calcium supplementation, moderate dairy consumption, reduced red meat consumption, increased physical activity, decreased body mass index, and statin use decrease the risk of colorectal cancer and adenomatous polyps. Although increased alcohol intake and tobacco use are associated with an increased risk of colorectal cancer, there is no direct evidence that reducing alcohol consumption or smoking cessation decreases the risk.

来源:Am Fam Physician,查看原文。版权归原作者所有。

引用

  1. Wilkins T, McMechan D, Talukder A, et al. Colorectal Cancer Screening and Prevention. Am Fam Physician. 2018. PMID: 29763272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。